Trial Design Principles for Patients at High Bleeding Risk Undergoing PCI-Reference-Cited by-同舟云学术

Trial Design Principles for Patients at High Bleeding Risk Undergoing PCI

Published:2020-09 Issue:12 Volume:76 Page:1468-1483
ISSN:0735-1097
Container-title:Journal of the American College of Cardiology
language:en
Short-container-title:Journal of the American College of Cardiology

Author:

Capodanno Davide,Morice Marie-Claude,Angiolillo Dominick J.,Bhatt Deepak L.,Byrne Robert A.,Colleran Roisin,Cuisset Thomas,Cutlip Donald,Eerdmans Pedro,Eikelboom John,Farb Andrew,Gibson C. Michael,Gregson John,Haude Michael,James Stefan K.,Kim Hyo-Soo,Kimura Takeshi,Konishi Akihide,Leon Martin B.,Magee P.F. Adrian,Mitsutake Yoshiaki,Mylotte Darren,Pocock Stuart J.,Rao Sunil V.,Spitzer Ernest,Stockbridge Norman,Valgimigli Marco,Varenne Olivier,Windhovel Ute,Krucoff Mitchel W.,Urban Philip,Mehran Roxana

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference72 articles.

1. Application of the Academic Research Consortium high bleeding risk criteria in an all-comers registry of percutaneous coronary intervention;Natsuaki;Circ Cardiovasc Interv,2019

2. Validation of bleeding risk criteria (ARC-HBR) in patients undergoing percutaneous coronary intervention and comparison with contemporary bleeding risk scores;Ueki;EuroIntervention,2020

3. Validation of the Academic Research Consortium high bleeding risk criteria in a contemporary PCI population;Cao;J Am Coll Cardiol,2020

4. Polymer-free drug-coated coronary stents in patients at high bleeding risk;Urban;N Engl J Med,2015

5. Is bare-metal stent implantation still justifiable in high bleeding risk patients undergoing percutaneous coronary intervention?;Ariotti;J Am Coll Cardiol Intv,2016

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Consecutive or selectively included high bleeding risk patients in the MASTER DAPT screening log and trial;European Journal of Internal Medicine;2024-08

2. One-Month Versus Three-Month Dual-Antiplatelet Therapy in High Bleeding Risk Patients With Chronic Kidney Disease;The American Journal of Cardiology;2024-08

3. One-month DAPT after biodegradable-polymer everolimus-eluting stent implantation in patients at high-bleeding risk: an individual patient data pooled analysis of the SENIOR and POEM trials;European Heart Journal Open;2024-07

4. Safety and efficacy of the latest generation biodegradable polymer-coated ultrathin sirolimus-eluting stent in the treatment of coronary artery disease in a European all-comer population with or without high bleeding risk: The Cruz HBR Registry;Minerva Cardiology and Angiology;2024-06

5. Defining high bleeding risk in patients undergoing transcatheter aortic valve implantation: a VARC-HBR consensus document;EuroIntervention;2024-05